{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T04:02:37Z","timestamp":1762574557836,"version":"build-2065373602"},"reference-count":30,"publisher":"University of Tokushima Faculty of Medicine","issue":"3.4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2025]]},"DOI":"10.2152\/jmi.72.375","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:07:31Z","timestamp":1762207651000},"page":"375-384","source":"Crossref","is-referenced-by-count":0,"title":["Association of lipids in lipoprotein subfractions with liver fibrosis in a mouse model of metabolic dysfunction\u2013associated steatohepatitis"],"prefix":"10.2152","volume":"72","author":[{"given":"Honoka","family":"Nakahara","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"},{"name":"Student Lab., Faculty of Medicine, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Ichimura-Shimizu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"},{"name":"Department of Food Science and Nutrition, Nara Women\u2019s University, Nara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Tachibana","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orgil","family":"Jargalsaikhan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai","family":"Qinyi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Miyakami","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Food Science and Nutrition, Nara Women\u2019s University, Nara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne C, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer D, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot B, Korenjak M, Kowdley K, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell E, Roden M, Romero-Gomez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, group NNc:A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023","DOI":"10.1097\/HEP.0000000000000520"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, Racila A, Hunt S, Beckerman R:The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology 64:1577-86, 2016","DOI":"10.1002\/hep.28785"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, Stal P, Wong VW, Kechagias S, Hultcrantz R, Loomba R:Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease:Systematic review and meta-analysis. Hepatology 65:1557-65, 2017","DOI":"10.1002\/hep.29085"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M:Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917-23, 2003","DOI":"10.1053\/jhep.2003.50161"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hussain A, Patel PJ, Rhodes F, Srivastava A, Patch D, Rosenberg W:Decompensated cirrhosis is the commonest presentation for NAFLD patients undergoing liver transplant assessment. Clin Med (Lond) 20:313-8, 2020","DOI":"10.7861\/clinmed.2019-0250"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Network NSCR:Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-21, 2005","DOI":"10.1002\/hep.20701"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Byrne CD, Targher G:Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. Diabetes Obes Metab 24 Suppl 2:28-43, 2022","DOI":"10.1111\/dom.14484"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. (EASL) EAftSotL, (EASD) EAftSoD, (EASO) EAftSoO:EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. Obes Facts 9:65-90, 2016","DOI":"10.1159\/000443344"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Thampanitchawong P, Piratvisuth T:Liver biopsy:complications and risk factors. World J Gastroenterol 5:301-4, 1999","DOI":"10.3748\/wjg.v5.i4.301"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Abe M, Miyake T, Kuno A, Imai Y, Sawai Y, Hino K, Hara Y, Hige S, Sakamoto M, Yamada G, Kage M, Korenaga M, Hiasa Y, Mizokami M, Narimatsu H:Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol 50:776-84, 2015","DOI":"10.1007\/s00535-014-1007-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E:Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease. World J Gastroenterol 24:1239-49, 2018","DOI":"10.3748\/wjg.v24.i11.1239"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Baranova A, Younossi ZM:The future is around the corner:Noninvasive diagnosis of progressive nonalcoholic steatohepatitis. Hepatology 47:373-5, 2008","DOI":"10.1002\/hep.22140"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Anstee QM, Lawitz EJ, Alkhouri N, Wong VW, Romero-Gomez M, Okanoue T, Trauner M, Kersey K, Li G, Han L, Jia C, Wang L, Chen G, Subramanian GM, Myers RP, Djedjos CS, Kohli A, Bzowej N, Younes Z, Sarin S, Shiffman ML, Harrison SA, Afdhal NH, Goodman Z, Younossi ZM:Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH:Baseline Data From the STELLAR Trials. Hepatology 70:1521-30, 2019","DOI":"10.1002\/hep.30842"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Reinson T, Byrne CD, Patel J, El-Gohary M, Moore M:Transient elastography in patients at risk of liver fibrosis in primary care:a follow-up study over 54 months. BJGP Open 5, 2021","DOI":"10.3399\/BJGPO.2021.0145"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. El-Serag HB, Tran T, Everhart JE:Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126:460-8, 2004","DOI":"10.1053\/j.gastro.2003.10.065"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ruhl CE, Everhart JE:Epidemiology of nonalcoholic fatty liver. Clin Liver Dis 8:501-19, vii, 2004","DOI":"10.1016\/j.cld.2004.04.008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O\u2019Donnell CJ, Fox CS:Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat:the Framingham Heart Study. Hepatology 51:1979-87, 2010","DOI":"10.1002\/hep.23593"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yatsuzuka S, Shimomura Y, Akuzawa M, Ando Y, Kobayashi I, Nakano T, Tokita Y, Nagamine T, Ono H, Tanaka A, Schaefer E, Nakajima K:Plasma adiponectin is a more specific marker of fatty liver than a marker of metabolic syndrome in Japanese men. Ann Clin Biochem 51:68-79, 2014","DOI":"10.1177\/0004563213487892"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Imajo K, Hyogo H, Yoneda M, Honda Y, Kessoku T, Tomeno W, Ogawa Y, Taguri M, Mawatari H, Nozaki Y, Fujita K, Kirikoshi H, Saito S, Sumida Y, Ono M, Wada K, Nakajima A, Eguchi Y:LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver:a multicenter cross-sectional study. PLoS One 9:e115403, 2014","DOI":"10.1371\/journal.pone.0115403"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sonmez A, Nikolic D, Dogru T, Ercin CN, Genc H, Cesur M, Tapan S, Karslio\u011flu Y, Montalto G, Banach M, Toth PP, Bagci S, Rizzo M:Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease. J Clin Lipidol 9:576-82, 2015","DOI":"10.1016\/j.jacl.2015.03.010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chancharme L, Th\u00e9rond P, Nigon F, Lepage S, Couturier M, Chapman MJ:Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler Thromb Vasc Biol 19:810-20, 1999","DOI":"10.1161\/01.ATV.19.3.810"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. St-Pierre AC, Cantin B, Dagenais GR, Mauri\u00e8ge P, Bernard PM, Despr\u00e9s JP, Lamarche B:Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men:13-year follow-up data from the Qu\u00e9bec Cardiovascular Study. Arterioscler Thromb Vasc Biol 25:553-9, 2005","DOI":"10.1161\/01.ATV.0000154144.73236.f4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, Couper D, Virani SS, Kathiresan S, Boerwinkle E, Ballantyne CM:Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease:the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol 34:1069-77, 2014","DOI":"10.1161\/ATVBAHA.114.303284"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Corey KE, Vuppalanchi R, Wilson LA, Cummings OW, Chalasani N, CRN N:NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels. Aliment Pharmacol Ther 41:301-9, 2015","DOI":"10.1111\/apt.13035"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nagata KO, Nakada C, Kasai RS, Kusumi A, Ueda K:ABCA1 dimer-monomer interconversion during HDL generation revealed by single-molecule imaging. Proc Natl Acad Sci U S A 110:5034-9, 2013","DOI":"10.1073\/pnas.1220703110"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Rye KA, Bursill CA, Lambert G, Tabet F, Barter PJ:The metabolism and anti-atherogenic properties of HDL. J Lipid Res 50 Suppl:S195-200, 2009","DOI":"10.1194\/jlr.R800034-JLR200"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ahmad Z, Subramanyam L, Szczepaniak L, Simha V, Adams-Huet B, Garg A:Cholic acid for hepatic steatosis in patients with lipodystrophy:a randomized, controlled trial. Eur J Endocrinol 168:771-8, 2013","DOI":"10.1530\/EJE-12-0969"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ichimura-Shimizu M, Omagari K, Yamashita M, Tsuneyama K:Development of a novel mouse model of diet-induced nonalcoholic steatohepatitis-related progressive bridging fibrosis. Biosci Biotechnol Biochem 85:941-7, 2021","DOI":"10.1093\/bbb\/zbaa107"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Girona J, Amig\u00f3 N, Ibarretxe D, Plana N, Rodr\u00edguez-Borjabad C, Heras M, Ferr\u00e9 R, Gil M, Correig X, Masana L:HDL Triglycerides:A New Marker of Metabolic and Cardiovascular Risk. Int J Mol Sci 20, 2019","DOI":"10.3390\/ijms20133151"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ottestad IO, Halvorsen B, Balstad TR, Otterdal K, Borge GI, Brosstad F, Myhre AM, Ose L, Nenseter MS, Holven KB:Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux. J Nutr 136:877-81, 2006","DOI":"10.1093\/jn\/136.4.877"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/72\/3.4\/72_375\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:57:42Z","timestamp":1762574262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/72\/3.4\/72_375\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"3.4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.72.375","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"type":"print","value":"1343-1420"},{"type":"electronic","value":"1349-6867"}],"subject":[],"published":{"date-parts":[[2025]]}}}